Although several mechanisms, including RNA toxicity, post-receptor signaling defects, loss of DMPK protein function, and inflammation, have been implicated in insulin resistance in DM1, the relative importance and interactions of these mechanisms across different patients and disease stages remain unclear. This evidence concerns the gene DMPK and myotonic dystrophy type 1.